The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2021 | Risk stratification for CTCL
Lauren Pinter-Brown, MD, of UCI Health, Chao Family Comprehensive Cancer Center, Orange, CA, discusses the debate around risk stratification for cutaneous T-cell lymphoma (CTCL) based on the diagnosis, the stage of disease, and other presentations of the disease, as well as existing prototype registries including PROCLIPI. This interview took place during the ninth annual meeting of the Society of Hematologic Oncology (SOHO 2021) congress.
